Showing results (1351-1360 of 1,385) with videos related to
Sort By:
Pageof 139
The Lancet. Gastroenterology & Hepatology|March 3, 2019
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort studyNicholas A Kennedy, Graham A Heap, Harry D Green, et al.Nature|November 17, 2022
Enterococci enhance Clostridioides difficile pathogenesisAlexander B Smith, Matthew L Jenior, Orlaith Keenan, et al.The Lancet. Gastroenterology & Hepatology|February 6, 2022
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control studyJames L Alexander, Nicholas A Kennedy, Hajir Ibraheim, et al.Stroke|December 22, 2023
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial ModelingStephanie Hage, Serena Kinkade, Romuald Girard, et al.Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Cavernous Angioma Symptomatic Hemorrhage (CASH) Trial Readiness II: Imaging Biomarkers and Trial ModelingStephanie Hage, Serena Kinkade, Romuald Girard, et al.Cellular and Molecular Gastroenterology and Hepatology|February 12, 2016
Chemokine (C-C Motif) Receptor 2 Mediates Dendritic Cell Recruitment to the Human Colon but Is Not Responsible for Differences Observed in Dendritic Cell Subsets, Phenotype, and Function Between the Proximal and Distal ColonDavid Bernardo, Lydia Durant, Elizabeth R Mann, et al.Journal of Crohn'S & Colitis|January 26, 2026
Mechanistic insights into FMT for the treatment of ulcerative colitis: analysis of the STOP-Colitis trialMohammed Nabil Quraishi, Catherine A Moakes, Mehmet Yalchin, et al.Annals of the American Thoracic Society|March 10, 2026
A "PalliPulm" framework to improve palliative care education and practice in pulmonary-critical care medicine: an official American Thoracic Society Workshop ReportAnand S Iyer, Kathleen M Akgün, Brynn Bowman, et al.Gut|March 23, 2021
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximabNicholas A Kennedy, James R Goodhand, Claire Bewshea, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2019
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trialJ M Weiss, T Csoszi, M Maglakelidze, et al.Pageof 139